NasdaqCM exchange. Sector: Healthcare. Industry: Biotechnology. Location United States, Tustin.

Avid Bioservices, Inc. [CDMOUnited States

18.36USD0.76 (-4.14%)

• At close Wed Oct 05 2022

905,863,872 USD
MARKET CAP
.
PE
1.947
BETA (5y)
-0.004
EPS

profit

774%

for 5 years

profit

377%

for 3 years

profit

178%

for 2 years

profit

26%

for 1 year

profit

-3%

for this year

About Avid Bioservices, Inc.

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Drug substance and biologics contract manufacturing organization (CDMO) located in California experienced in process development, analytical services, CGMP clinical and commercial manufacturing, and viral vector services

Avid Bioservices, Inc.
https://www.avidbio.com
© 2022 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.